• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form 20-F/A filed by Aegon Ltd. New York Registry Shares

    4/1/26 6:03:30 AM ET
    $AEG
    Life Insurance
    Finance
    Get the next $AEG alert in real time by email
    20-F/A
    trueFY0000769218--12-31 0000769218 2025-01-01 2025-12-31 0000769218 dei:BusinessContactMember 2025-01-01 2025-12-31 0000769218 ifrs-full:OrdinarySharesMember 2025-12-31 0000769218 aeg:CommonStockSeriesBMember 2025-12-31 xbrli:shares
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    -
    FORM 20-F/A
    (Amendment No. 1)
    -
    (Mark One)
    ☐
     REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g)
     OF THE
    SECURITIES EXCHANGE ACT OF 1934
    OR
    ☒
     ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
    SECURITIES EXCHANGE ACT OF 1934
    For the fiscal year ended December 31, 2025
    OR
    ☐
     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
    SECURITIES EXCHANGE ACT OF 1934
    For the transition period from ______________ to__________________
    OR
    ☐
     SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
    SECURITIES EXCHANGE ACT OF 1934
    Commission file number
    1-10882
    -
    Aegon Ltd.
    (Exact name of Registrant as specified in its charter)
    -
    Not Applicable
    (Translation of Registrant’s name into English)
    Bermuda
    (Jurisdiction of incorporation or organization)
    World Trade Center Schiphol, Schiphol Boulevard 223, 1118 BH Schiphol, The Netherlands
    (Address of principal executive offices)
    Duncan Russell
    Chief Financial Officer
    Aegon Ltd.
    World Trade Center Schiphol, Schiphol Boulevard 223,
    1118 BH Schiphol
    ,
    The Netherlands
    +31-70-3447305
    [email protected]
    (Name, Telephone,
    E-mail
    and/or Facsimile number and Address of Company Contact Person)
    Securities registered or to be registered pursuant to Section 12(b) of the Act.
     
    Title of each class
      
    Trading Symbol(s)
      
    Name of each exchange on which registered
    Common shares, par value EUR 0.12 per share
      
    AEG
      
    New York Stock Exchange
    5.500% Fixed-to-Floating Rate
    Subordinated Notes due 2048
      
    AG48
      
    New York Stock Exchange
    5.100% Subordinated Notes due 2049
    issued by Aegon Funding Company LLC
      
    AEFC
      
    New York Stock Exchange
    Securities registered or to be registered pursuant to Section 12(g) of the Act.
    Not applicable
    (Title of Class)
    Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act.
    Not applicable
    (Title of Class)

    Table of Contents
    Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report: 1,573,119,870 common shares and 335,830,640 common shares B
    Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act
    ☒
     Yes No 
    ☐
    If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
    ☐
     Yes No 
    ☒
    Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    ☒
     Yes No
    ☐
    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of
    Regulation S-T (§
    232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
    ☒
     Yes No 
    ☐
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,
    a non-accelerated
    filer, or an emerging growth company. See definition of “large accelerated filer, “accelerated filer,” and “emerging growth company” in
    Rule 12b-2 of
    the Exchange Act.
    ☒
     Large accelerated filer 
    ☐
     Accelerated filer 
    ☐
    Non-accelerated filer 
    ☐
     Emerging growth company
    If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
    †
    provided pursuant to Section 13(a) of the Exchange Act. 
    ☐
    †
    The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards
    Board to its Accounting Standards Codification after April 5, 2012.
    Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness
    of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. 
    ☒
    If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. 
    ☐
    Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §
    240.10D-1(b). 
    ☐
    Indicate by checkmark which basis of accounting the registrant has used to prepare the financial statements included in this filing:
    ☐
     U.S. GAAP 
    ☒
     International Financial Reporting Standards as issued by the International Accounting Standards Board 
    ☐
     Other
    If “other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant as elected to follow. 
    ☐
     Item 17 
    ☐
     Item 18
    If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in
    Rule12b-2 of
    the Exchange Act). 
    ☐
     Yes No 
    ☒

    Table of Contents
    EXPLANATORY NOTE
    This Amendment No. 1 (“Amendment No. 1”) to the Annual Report on Form
    20-F
    of Aegon Ltd. (“Aegon”) for the fiscal year ended December 31, 2025 filed on March 26, 2026 (the “2025 Form
    20-F”)
    is being filed to include the audited financial statements and related notes of ASR Nederland N.V. (“ASR”), and the audit report of KPMG Accountants N.V. relating thereto, as required
    by Rule 3-09 of Regulation S-X under
    the Securities Exchange Act of 1934, as amended.
    Aegon owns less than
    50% non-controlling interest
    in ASR and accounts for ASR using the equity method of accounting. ASR did not meet the significant subsidiary test for the year ended December 31, 2025, but met the significant subsidiary test for the year ended December 31, 2024. Accordingly, this Amendment No. 1 includes
    ASR’s
    audited financial statements and related notes for the year ended December 31, 2025, which include comparative financial information for the year ended December 31, 2024, together with the independent auditor’s report thereon.
    This Amendment No. 1 consists of a cover page, this explanatory note, the signature page and the exhibits for (i) audited financial statements of ASR for the year ended December 31, 2025 prepared in accordance with International Financial Reporting Standards (IFRS) as adopted by the European Union, (ii) the consent of KPMG Accountants N.V., the independent auditors of ASR, (iii) certifications of the Chief Executive Officer and the Chief Financial Officer of Aegon.
    Other than as expressly set forth above, this Amendment No. 1 does not, and does not purport to, revise, update, amend or restate the information presented in, or any exhibits to, the 2025 Form
    20-F
    or reflect any events that have occurred subsequent to the filing of the 2025 Form
    20-F.
     
    3


    Description

     

    12.3    Certification of Lard Friese pursuant to rule 13a-14(a) or 15d-14 of the Securities Exchange Act of 1934    Filed herewith
    12.4    Certification Duncan Russell pursuant to rule 13a-14(a) or 15d-14 of the Securities Exchange Act of 1934    Filed herewith
    15.4    Consent of KPMG Accountants N.V., the independent auditors of ASR    Filed herewith
    99.2    Audited financial statements of ASR for the year ended December 31, 2025    Filed herewith

     

    4


    SIGNATURES

    The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this Amendment No. 1 to the Annual Report on Form 20-F on its behalf.

    Schiphol, the Netherlands, April 1, 2026

     

    /s/ Duncan Russell

     

                    
    Duncan Russell
    Chief Financial Officer
    Aegon Ltd.

     

    5

    Get the next $AEG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEG

    DatePrice TargetRatingAnalyst
    1/7/2026Hold
    Deutsche Bank
    12/3/2025Buy → Neutral
    UBS
    5/7/2025Neutral → Outperform
    BNP Paribas Exane
    10/22/2024Neutral → Buy
    UBS
    5/28/2024Buy → Neutral
    UBS
    6/9/2023Hold → Buy
    HSBC Securities
    4/4/2023Neutral
    BofA Securities
    9/13/2022Hold → Buy
    Societe Generale
    More analyst ratings

    $AEG
    SEC Filings

    View All

    SEC Form 6-K filed by Aegon Ltd. New York Registry Shares

    6-K - AEGON LTD. (0000769218) (Filer)

    4/1/26 6:10:05 AM ET
    $AEG
    Life Insurance
    Finance

    Amendment: SEC Form 20-F/A filed by Aegon Ltd. New York Registry Shares

    20-F/A - AEGON LTD. (0000769218) (Filer)

    4/1/26 6:03:30 AM ET
    $AEG
    Life Insurance
    Finance

    SEC Form 6-K filed by Aegon Ltd. New York Registry Shares

    6-K - AEGON LTD. (0000769218) (Filer)

    3/26/26 6:21:26 AM ET
    $AEG
    Life Insurance
    Finance

    $AEG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AM Best Affirms Credit Ratings of Members of Aegon Ltd.'s U.S. Subsidiaries

    AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings of "a+" (Excellent) of the U.S. life/health (L/H) subsidiaries of Aegon Ltd. (Bermuda) (NYSE:AEG). Aegon Ltd.'s U.S. L/H companies are Transamerica Life Insurance Company (Cedar Rapids, IA) and Transamerica Financial Life Insurance Company (Harrison, NY) both referred to as Aegon USA Group (Aegon USA). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect Aegon USA's balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, favorable business profile and appropriate enterprise risk management. AM Best expects

    2/13/26 9:24:00 AM ET
    $AEG
    Life Insurance
    Finance

    AM Best Affirms Credit Ratings of Members of Aegon Ltd.'s U.S. Subsidiaries

    AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings of "a+" (Excellent) of the U.S. life/health (L/H) subsidiaries of Aegon Ltd. (Bermuda) (NYSE:AEG). Aegon Ltd.'s U.S. L/H companies are Transamerica Life Insurance Company (Cedar Rapids, IA) and Transamerica Financial Life Insurance Company (Harrison, NY) and referred to collectively as Aegon USA Group (Aegon USA). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect Aegon USA's balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, favorable business profile and appropriate enterprise risk management. AM

    1/28/25 5:31:00 PM ET
    $AEG
    Life Insurance
    Finance

    Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on Aegon Ltd. (NYSE: AEG, Euronext: AGN)

    NOTE TO EDITORS: The Following is an Investment Opinion Issued by Spruce Point Capital Management Illustrates Why We Believe World Financial Group Operates an Aggressive Multi-Level-Marketing Business but Has Faced Allegations of Being a Pyramid Scheme Provides Evidence of FTC "Warning Signs" Such as Aggressive Claims in Their Recruiting and Sales Tactics Questions Management's Choice to Rely on Indexed-Universal Life Insurance Sales for Growth Expresses Concerns Over an Upstart Competitor Founded by One of World Financial Group's Former Top Producing Agents and the Impact It Could Have On World Financial Group's Recruiting Goals Estimates That a Sum-of-Parts Illustrative Valuatio

    12/16/24 7:30:00 AM ET
    $AEG
    Life Insurance
    Finance

    $AEG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4 filed by Russell Duncan James

    4/A - AEGON LTD. (0000769218) (Issuer)

    4/1/26 4:30:01 PM ET
    $AEG
    Life Insurance
    Finance

    SEC Form 4 filed by Russell Duncan James

    4 - AEGON LTD. (0000769218) (Issuer)

    3/27/26 4:30:29 PM ET
    $AEG
    Life Insurance
    Finance

    SEC Form 4 filed by Fuller Wilford H.

    4 - AEGON LTD. (0000769218) (Issuer)

    3/27/26 4:30:24 PM ET
    $AEG
    Life Insurance
    Finance

    $AEG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Deutsche Bank resumed coverage on Aegon N.V.

    Deutsche Bank resumed coverage of Aegon N.V. with a rating of Hold

    1/7/26 9:08:42 AM ET
    $AEG
    Life Insurance
    Finance

    Aegon N.V. downgraded by UBS

    UBS downgraded Aegon N.V. from Buy to Neutral

    12/3/25 11:42:57 AM ET
    $AEG
    Life Insurance
    Finance

    Aegon N.V. upgraded by BNP Paribas Exane

    BNP Paribas Exane upgraded Aegon N.V. from Neutral to Outperform

    5/7/25 8:33:19 AM ET
    $AEG
    Life Insurance
    Finance

    $AEG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Aegon Ltd. New York Registry Shares (Amendment)

    SC 13G/A - AEGON LTD. (0000769218) (Subject)

    2/9/24 12:59:27 PM ET
    $AEG
    Life Insurance
    Finance

    SEC Form SC 13G/A filed by Aegon Ltd. New York Registry Shares (Amendment)

    SC 13G/A - AEGON LTD. (0000769218) (Subject)

    2/8/24 12:26:49 PM ET
    $AEG
    Life Insurance
    Finance

    SEC Form SC 13D/A filed by Aegon Ltd. New York Registry Shares (Amendment)

    SC 13D/A - AEGON LTD. (0000769218) (Subject)

    12/29/23 6:43:57 AM ET
    $AEG
    Life Insurance
    Finance

    $AEG
    Financials

    Live finance-specific insights

    View All

    Aegon completes share buyback program

    Aegon has completed the share buyback program announced on September 17, 2021, aimed at neutralizing the dilutive effect of the 2021 interim dividend paid in shares. The repurchased shares will be held as treasury shares and will be used to pay future dividends in shares. Between October 1, 2021 and October 26, 2021 common shares for an amount of EUR 96 million were repurchased. A total of 21,531,927 common shares were repurchased at an average price of EUR 4.46 per share. For further details visit our share buyback updates page at aegon.com. About Aegon Aegon's roots go back more than 175 years – to the first half of the nineteenth century. Since then, Aegon has grown into an internati

    10/27/21 2:00:00 AM ET
    $AEG
    Life Insurance
    Finance

    Aegon to repurchase shares to neutralize impact of 2021 interim dividend paid in shares

    Aegon announced today that it will repurchase common shares for an amount of EUR 96 million to neutralize the dilutive effect of its 2021 interim dividend paid in shares. These shares will be held as treasury shares and will be used to pay future dividends in shares. Shareholders were given the opportunity to choose between receiving the 2021 interim dividend of EUR 0.08 per common share in cash or in shares. 58% of shareholders elected to receive the interim dividend in shares. The repurchase will commence on October 1, 2021 and is expected to be completed on or before October 26, 2021. Aegon will engage a third party to execute the transactions on its behalf. The common shares will be r

    9/17/21 2:00:00 AM ET
    $AEG
    Life Insurance
    Finance

    Aegon completes share buyback program

    Aegon has completed the share buyback program to neutralize the dilutive effect of the 2020 final dividend paid in shares and certain share-based variable compensation plans for senior management, as announced on July 7, 2021. The repurchased shares will be held as treasury shares and will either be used to cover future dividends to be paid in shares or will be allocated to the participants of share-based variable compensation plans. Between July 8, 2021 and August 20, 2021 a total of 35,933,035 common shares were repurchased, at an average price of EUR 3.7013 per share. For further details, visit our share buyback updates page on aegon.com. About Aegon Aegon's roots go back more than

    8/23/21 2:00:00 AM ET
    $AEG
    Life Insurance
    Finance